AbCellera Is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of Its DARPA P3 Program Life Science
Wuhan’s BravoVax Signs Letter of Intent with Atlanta’s GeoVax to Develop Coronavirus Vaccine Life Science
Healthcare Roundup – Itamar -4.7% after filing for $30M ADS offering, Hepion Pharma +46% on positive NASH data Life Science
Technology Roundup – Foxconn doesn’t expect coronavirus impact, Apple execs talk coronavirus impact, iPhone strength Technology
Technology Roundup – Guidewire gains a rare bear, Apple shares hit by China’s coronavirus worries Life Science
TILT Biotherapeutics Signs a Licensing Deal with Biotheus, Inc for Cancer Therapy with Oncolytic Virus TILT-123 Life Science
CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer’s regorafenib Life Science
Healthcare Roundup – Innovative Industrial Properties prices public offering, Bayer cuts stake in CRISPR Therapeutics Life Science
Technology Roundup – F5 Networks closes Shape Security acquisition, Activision Blizzard teams with Google, YouTube Technology
BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market Life Science
Procter & Gamble says it is monitoring China coronavirus and its impact on travel, consumer confidence Life Science
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody Life Science
